ScripThe turn of the year witnessed a spike in venture capital and private equity funding deals in China, with several valued at around the $100m level. A string of four large financings around late Decemb
ScripBolt-on acquisitions and mergers between Chinese biotechs and major drug makers had not yet come into fashion over the past year, although the two groups continued to pursue tie-ups in their efforts t
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. TiumBio, Hansoh Ink $170m Endometr
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Juniper Acquires Kolon’s Cell-Mediated